Sec Form 13G Filing - Lundbeckfond Invest A/S filing for OnKure Therapeutics, Inc. (OKUR) - 2025-02-06

Insider filing report for Changes in Beneficial Ownership

  • Schedule 13G & 13D forms are used to report a party's ownership of stock which exceeds 5% of a company's total stock issue.
  • Schedule 13G is a shorter version of Schedule 13D with fewer reporting requirements.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>





Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
Checkbox not checked   Rule 13d-1(b)
Checkbox not checked   Rule 13d-1(c)
Checkbox checked   Rule 13d-1(d)






SCHEDULE 13G




SCHEDULE 13G




SCHEDULE 13G


 
Lundbeckfond Invest A/S
 
Signature:/s/ Lene Skole
Name/Title:By Lene Skole, Chief Executive Officer & Attorney-in-Fact
Date:02/06/2025
 
Signature:/s/ Christian Elling
Name/Title:By Christian Elling, Attorney-in-Fact
Date:02/06/2025
 
Lene Skole
 
Signature:/s/ Lene Skole
Name/Title:Lene Skole
Date:02/06/2025
Exhibit Information

Exhibit 99.1Joint Filing Agreement, dated January 26, 2022, among the Reporting Persons (incorporated by reference to Exhibit 1 to Schedule 13G filed on January 26, 2022)

primary_doc.xml